文献速递生殖医学产科

医学辅助生殖与子代脐血DNA甲基化的关联:多队列研究

Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究基于ALSPAC与MoBa队列的病例对照设计,比较医学辅助生殖受孕者与自然受孕对照的脐血DNA甲基化,荟萃分析发现5个CpG位点存在关联,但在CHART队列中均未重复,未提供强证据支持医学辅助生殖与婴儿血细胞DNA甲基化变异相关。

要点

  • ALSPAC与MoBa荟萃分析发现5个CpG位点与医学辅助生殖受孕相关(FDR校正P<0.05)。
  • 上述5个位点关联在CHART队列中均未重复。
  • 关联位点位于调控区,提示医学辅助生殖诱导的高甲基化可能有功能作用。

核心结论

  • 本研究未提供强证据表明医学辅助生殖受孕与婴儿血细胞DNA甲基化变异相关。

研究设计与样本

  • 病例对照研究:发现队列含205例医学辅助生殖受孕与2439例自然受孕对照,重复队列含149例ART与58例非ART对照。
  • 在ALSPAC与MoBa两个子样本中检测脐血>450 000个CpG位点并行荟萃分析。

主要发现

  • 荟萃分析发现5个CpG位点与医学辅助生殖受孕相关(FDR校正P<0.05),注释至2个基因。
  • 各CpG位点甲基化百分比差异Beta值:cg24051276为0.23(95%CI 0.15,0.31);cg00012522为0.47(95%CI 0.31,0.63);cg17855264为0.31(95%CI 0.20,0.43);cg17132421为0.30(95%CI 0.18,0.42);cg18529845为0.41(95%CI 0.25,0.57)。
  • 其中3个位点甲基化此前曾与癌症、衰老、HIV感染和神经系统疾病相关联。
  • 上述关联在CHART队列中均未重复。
  • 位于调控区的CpG位点显示医学辅助生殖诱导的高甲基化可能有功能作用(基于推定的转录因子结合与染色质重塑)。

临床怎么用

  • 医学辅助生殖受孕新生儿脐血白细胞存在DNA甲基化差异,若关联真实且因果,可能对子代健康有长期影响。

局限性

  • 研究把握度可能不足。
  • 医学辅助生殖操作类型存在异质性,人群间也存在异质性,可能影响结果。
  • 需要更大规模研究以识别可重复的出生时DNA甲基化变异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is cord blood DNA methylation associated with having been conceived by medically assisted reproduction? SUMMARY ANSWER: This study does not provide strong evidence of an association of conception by medically assisted reproduction with variation in infant blood cell DNA methylation. WHAT IS KNOWN ALREADY: Medically assisted reproduction consists of procedures used to help infertile/subfertile couples conceive, including ART. Due to its importance in gene regulation during early development programming, DNA methylation and its perturbations associated with medically assisted reproduction could reveal new insights into the biological effects of assisted reproductive technologies and potential adverse offspring outcomes. STUDY DESIGN, SIZE, DURATION: We investigated the association of DNA methylation and medically assisted reproduction using a case-control study design (N = 205 medically assisted reproduction cases and N = 2439 naturally conceived controls in discovery cohorts; N = 149 ART cases and N = 58 non-ART controls in replication cohort). PARTICIPANTS/MATERIALS, SETTINGS, METHODS: We assessed the association between medically assisted reproduction and DNA methylation at birth in cord blood (205 medically assisted conceptions and 2439 naturally conceived controls) at >450 000 CpG sites across the genome in two sub-samples of the UK Avon Longitudinal Study of Parents and Children (ALSPAC) and two sub-samples of the Norwegian Mother, Father and Child Cohort Study (MoBa) by meta-analysis. We explored replication of findings in the Australian Clinical review of the Health of adults conceived following Assisted Reproductive Technologies (CHART) study (N = 149 ART conceptions and N = 58 controls). MAIN RESULTS AND THE ROLE OF CHANCE: The ALSPAC and MoBa meta-analysis revealed evidence of association between conception by medically assisted reproduction and DNA methylation (false-discovery-rate-corrected P-value < 0.05) at five CpG sites which are annotated to two genes (percentage difference in methylation per CpG, cg24051276: Beta = 0.23 (95% CI 0.15,0.31); cg00012522: Beta = 0.47 (95% CI 0.31, 0.63); cg17855264: Beta = 0.31 (95% CI 0.20, 0.43); cg17132421: Beta = 0.30 (95% CI 0.18, 0.42); cg18529845: Beta = 0.41 (95% CI 0.25, 0.57)). Methylation at three of these sites has been previously linked to cancer, aging, HIV infection and neurological diseases. None of these associations replicated in the CHART cohort. There was evidence of a functional role of medically assisted reproduction-induced hypermethylation at CpG sites located within regulatory regions as shown by putative transcription factor binding and chromatin remodelling. LIMITATIONS, REASONS FOR CAUTIONS: While insufficient power is likely, heterogeneity in types of medically assisted reproduction procedures and between populations may also contribute. Larger studies might identify replicable variation in DNA methylation at birth due to medically assisted reproduction. WIDER IMPLICATIONS OF THE FINDINGS: Newborns conceived with medically assisted procedures present with divergent DNA methylation in cord blood white cells. If these associations are true and causal, they might have long-term consequences for offspring health. STUDY FUNDING/COMPETING INTERESTS(S): This study has been supported by the US National Institute of Health (R01 DK10324), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 669545, European Union's Horizon 2020 research and innovation programme under Grant agreement no. 733206 (LifeCycle) and the NIHR Biomedical Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. Methylation data in the ALSPAC cohort were generated as part of the UK BBSRC funded (BB/I025751/1 and BB/I025263/1) Accessible Resource for Integrated Epigenomic Studies (ARIES, http://www.ariesepigenomics.org.uk). D.C., J.J., C.L.R. D.A.L and H.R.E. work in a Unit that is supported by the University of Bristol and the UK Medical Research Council (Grant nos. MC_UU_00011/1, MC_UU_00011/5 and MC_UU_00011/6). B.N. is supported by an NHMRC (Australia) Investigator Grant (1173314). ALSPAC GWAS data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (Contract no. N01-ES-75558), NIH/NINDS (Grant nos. (i) UO1 NS 047537-01 and (ii) UO1 NS 047537-06A1). For this work, MoBa 1 and 2 were supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01-ES-49019) and the Norwegian Research Council/BIOBANK (Grant no. 221097). This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, Project no. 262700.D.A.L. has received support from national and international government and charity funders, as well as from Roche Diagnostics and Medtronic for research unrelated to this study. The other authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Caramaschi D, Jungius J, Page CM, et al. Association of medically assisted reproduction with offspring cord blood DNA methylation across cohorts. Hum Reprod. 2021. PMID: 34136910. doi:10.1093/humrep/deab137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。